GSP 301 Placebo NS

DRUG4 trials

Sponsors

Glenmark Pharmaceuticals Ltd. India, Glenmark Specialty S.A.

Conditions

Seasonal Allergic RhinitisSeasonal Allergic Rhinitis (SAR)

Phase 2

To Study GSP 301 in Patients With Seasonal Allergic Rhinitis

CompletedNCT02318303

Glenmark Pharmaceuticals Ltd. IndiaSeasonal Allergic Rhinitis

Start: 2014-12-31End: 2015-02-28Updated: 2020-10-20

Phase 3

Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)

CompletedNCT02631551

Glenmark Specialty S.A.Seasonal Allergic Rhinitis

Start: 2016-03-31End: 2016-07-31Updated: 2018-09-25

Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)

CompletedNCT02870205

Glenmark Specialty S.A.Seasonal Allergic Rhinitis (SAR)

Start: 2016-08-31End: 2017-01-31Updated: 2018-04-06

Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)

CompletedNCT03463031

Glenmark Specialty S.A.Seasonal Allergic Rhinitis (SAR)

Start: 2018-03-16End: 2018-11-14Updated: 2019-10-08

Related Papers

Olopatadine plus mometasone for seasonal allergic rhinitis treatment: A pooled analysis of clinical trials

Brazilian Journal of Otorhinolaryngology2026-04-14

Efficacy and safety of GSP301 nasal spray in children aged 6 to 11 years with seasonal allergic rhinitis

Annals of Allergy Asthma & Immunology2022-08-0112 citations

Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis.

2019-11-1525 citations

Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis

Allergy and Asthma Proceedings2019-05-0341 citations

Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis

Annals of Allergy Asthma & Immunology2019-03-2261 citations